New CRISPR based gene-editing treatment targets root cause of kidney disease
A single-dose gene-editing therapy has shown it can correct the genetic cause of autosomal dominant polycystic kidney disease in preclinical...
A single-dose gene-editing therapy has shown it can correct the genetic cause of autosomal dominant polycystic kidney disease in preclinical...